DHAI — DIH Holding US Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- $133.80m
- $146.08m
- $55.00m
Annual income statement for DIH Holding US, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 47.5 | 49 | 55 |
| Cost of Revenue | |||
| Gross Profit | 28.2 | 24.8 | 34.5 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Total Operating Expenses | 58 | 59.5 | 55.2 |
| Operating Profit | -10.4 | -10.5 | -0.218 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -10.8 | -11.4 | -0.331 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -10.9 | -12.1 | -2.36 |
| Net Income Before Extraordinary Items | |||
| Net Income | -10.9 | -12.1 | -2.36 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -10.9 | -12.1 | -2.36 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.268 | -0.297 | -0.058 |
| Dividends per Share |